Search

Search Constraints

You searched for: Author/Creator Hubner, Richard

Search Results

1. Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?. (March 2016)

2. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. (November 2019)

4. What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature. Issue 10 (26th October 2022)

5. OGC O08 Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10mm in diameter. (7th December 2022)

6. NCMP-04. INCIDENCE AND OUTCOMES OF BRAIN METASTASES IN PATIENTS WITH EXTRA-PULMONARY NEUROENDOCRINE NEOPLASMS. (9th November 2020)

7. The Influence of Patients' Age on the Outcome of Treatment for Pancreatic Ductal Adenocarcinoma. Issue 2 (February 2020)

8. 11. Is age a barrier to optimal treatment, with curative intent, for pancreatic ductal adenocarcinoma?. Issue 11 (November 2018)